Methods of T Cell Depletion Trial (MoTD)
Conditions
Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndromes · Non Hodgkin Lymphoma · Hodgkin Lymphoma · Multiple Myeloma · Chronic Myelogenous Leukemia · Myelofibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital of Wales, Cardiff, Wales, United Kingdom
Contact: Study coordinator (Emma Kempshall)Queen Elizabeth Hospital, Birmingham, United Kingdom
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
Addenbrookes Hospital, Cambridge, United Kingdom
Queen Elizabeth Hospital Glasgow, Glasgow, United Kingdom
Contact: Study coordinator (Andrew Clark)St Jame's University Hospital, Leeds, United Kingdom
University College London Hospital, London, United Kingdom
King's College Hospital, London, United Kingdom
Contact: Study coordinator (Pramilla Krishnamurphy)Hammersmith Hospital, London, United Kingdom
Manchester Royal Infirmary, Manchester, United Kingdom
The Christie, Manchester, United Kingdom
Freeman Hospital, Newcastle upon Tyne, United Kingdom
Nottingham City Hospital, Nottingham, United Kingdom
Churchill Hospital, Oxford, United Kingdom
Derriford Hospital, Plymouth, United Kingdom
Royal Hallamshire Hospital, Sheffield, United Kingdom
The Royal Marsden Hospital, Sutton, United Kingdom
Study leads
Ronjon Professor Chakraverty
Study Director
Oxford Cancer & Haematology Centre, The Churchill Hospital, Old Road - Headington, Oxford, OX3 7LE Email: ronjon.chakraverty@ndcls.ox.ac.uk